Trial Profile

Phase I/II pharmacokinetic study of oral hydroxyprogesterone caproate [LPCN 1107] in healthy women

Status: Active, no longer recruiting

Phase of Trial: Phase I/II

Latest Information Update: 29 May 2014

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Hydroxyprogesterone (Primary)
Indications Preterm labour
Focus Pharmacokinetics

Most Recent Events

29 May 2014 New trial record
13 May 2014 This trial has completed enrolment, according to a Lipocine media release. Results are expected to be released in the second quarter of 2014.

You need to be a logged in or subscribed to view this content Request demo (opens in a new window)

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com